{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The drug, which directly counteracts the genetic defect that causes cystic fibrosis, might help as many as half of American patients.", "headline": {"main": "Cystic Fibrosis Drug Wins Approval of F.D.A. Advisory Panel", "print_headline": "Cystic Fibrosis Drug Wins Approval of an F.D.A. Panel"}, "abstract": "Food and Drug Administration advisory committee recommends approval for Orkambi, drug developed by Vertex Pharmaceuticals that could help nearly half of all patients with cystic fibrosis.", "print_page": "3", "word_count": "750", "_id": "55526c9e7988101fa1fbb638", "snippet": "The drug, which directly counteracts the genetic defect that causes cystic fibrosis, might help as many as half of American patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/05/13/business/cystic-fibrosis-drug-wins-approval-of-fda-advisory-panel.html", "multimedia": [{"subtype": "wide", "url": "images/2015/05/13/business/13DB-DRUG/13DB-DRUG-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/05/13/business/13DB-DRUG/13DB-DRUG-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/05/13/business/13DB-DRUG/13DB-DRUG-articleLarge.jpg", "height": 600, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/05/13/business/13DB-DRUG/13DB-DRUG-articleLarge.jpg", "xlargeheight": "600"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/05/13/business/13DB-DRUG/13DB-DRUG-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/05/13/business/13DB-DRUG/13DB-DRUG-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Vertex Pharmaceuticals Inc", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Cystic Fibrosis", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2015-05-13T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "Jim Greenwood of the Biotechnology Industry Organization calls for an examination of &#8220;the insurance industry&#8217;s recent expansion of the use of specialty tier cost-sharing, in which patients must pay a relatively high percentage of their drug costs.&#8221;", "headline": {"main": "Cost Barrier to Medicines", "kicker": "Letter", "print_headline": "Cost Barrier to Medicines", "content_kicker": "Letter"}, "abstract": null, "print_page": "22", "word_count": "189", "_id": "5551a9e479881071e80066f0", "snippet": "Jim Greenwood of the Biotechnology Industry Organization calls for an examination of &#8220;the insurance industry&#8217;s recent expansion of the use of specialty tier cost-sharing, in which patients must pay a relatively high percentage of their...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/05/12/opinion/cost-barrier-to-medicines.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Biotechnology and Bioengineering", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Biotechnology Industry Organization", "is_major": "N", "rank": "4", "name": "organizations"}], "byline": [], "document_type": "article", "pub_date": "2015-05-12T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "The West African nation, which is improving its health care systems, now has Ebola under control after being overwhelmed by the disease last year.", "headline": {"main": "Liberia, Ravaged by Ebola, Faces a Future Without It", "print_headline": "Seeing End of Ebola, Liberia Tries to Repair What Fueled It "}, "abstract": "Liberia, which is expected to be declared free of Ebola virus by World Health Organization, is making sweeping changes to health care system whose failings led country to become center of deadliest Ebola epidemic in history; nation has now gone 42 days since last victim was buried.", "print_page": "1", "word_count": "1592", "_id": "554ce33779881019e6225102", "snippet": "The West African nation, which is improving its health care systems, now has Ebola under control after being overwhelmed by the disease last year.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/05/09/world/africa/liberia-ravaged-by-ebola-faces-a-future-without-it.html", "multimedia": [{"subtype": "wide", "url": "images/2015/05/09/world/09EBOLA1/09EBOLA1-thumbWide-v2.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/05/09/world/09EBOLA1/09EBOLA1-thumbWide-v2.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/05/09/world/09EBOLA1/09EBOLA1-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/05/09/world/09EBOLA1/09EBOLA1-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/05/09/world/09EBOLA1/09EBOLA1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/05/09/world/09EBOLA1/09EBOLA1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Africa", "keywords": [{"value": "Ebola Virus", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Liberia", "is_major": "Y", "rank": "2", "name": "glocations"}, {"value": "Epidemics", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Hospitals", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Hygiene and Cleanliness", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Deaths (Fatalities)", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Humanitarian Aid", "is_major": "N", "rank": "8", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Norimitsu", "lastname": "ONISHI"}], "original": "By NORIMITSU ONISHI"}, "document_type": "article", "pub_date": "2015-05-09T00:00:00Z", "section_name": "World"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Numerous bills have been passed by Republican-controlled legislatures this year that make it harder for women to terminate their pregnancies.", "headline": {"main": "State Legislatures Put Up Flurry of Roadblocks to Abortion", "print_headline": "With Flurry of Bills, Republican Legislatures Make Abortions Harder to Get"}, "abstract": "Raft of new laws passed by number of Republican-led State Legislatures are making it harder for women around United States to obtain legal abortions, with 37 new rules in 11 states chipping away at availability of procedure; many doctors dispute assertions that legislation improves women's health, while pro-choice advocates say restrictions will result in more illegal abortions.", "print_page": "17", "word_count": "1036", "_id": "554c7b297988106d7dc1ff62", "snippet": "Numerous bills have been passed by Republican-controlled legislatures this year that make it harder for women to terminate their pregnancies.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/05/09/us/politics/state-legislatures-put-up-flurry-of-roadblocks-to-abortion.html", "multimedia": [{"subtype": "wide", "url": "images/2015/05/08/us/09ABORTIONweb01/09ABORTIONweb01-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/05/08/us/09ABORTIONweb01/09ABORTIONweb01-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/05/08/us/09ABORTIONweb01/09ABORTIONweb01-articleLarge.jpg", "height": 392, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/05/08/us/09ABORTIONweb01/09ABORTIONweb01-articleLarge.jpg", "xlargeheight": "392"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/05/08/us/09ABORTIONweb01/09ABORTIONweb01-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/05/08/us/09ABORTIONweb01/09ABORTIONweb01-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Politics", "keywords": [{"value": "Abortion", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "States (US)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "State Legislatures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Pregnancy and Childbirth", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Americans United for Life", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Planned Parenthood Federation of America", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Law and Legislation", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "American Civil Liberties Union", "is_major": "N", "rank": "8", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Frances", "lastname": "ROBLES"}], "original": "By FRANCES ROBLES"}, "document_type": "article", "pub_date": "2015-05-09T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "Federal health regulators say an experimental combination drug for cystic fibrosis developed by Vertex Pharmaceuticals Incorporated helped improve breathing in patients with the deadly inherited disease.", "headline": {"main": "FDA Questions Benefit of Cystic Fibrosis Drug From Vertex", "print_headline": "FDA Questions Benefit of Cystic Fibrosis Drug From Vertex"}, "abstract": null, "print_page": null, "word_count": "667", "_id": "554cb84c7988106d7dc1ffea", "snippet": "Federal health regulators say an experimental combination drug for cystic fibrosis developed by Vertex Pharmaceuticals Incorporated helped improve breathing in patients with the deadly inherited disease.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/05/08/us/politics/ap-us-cystic-fibrosis-drug-fda.html", "multimedia": [], "subsection_name": "Politics", "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-05-08T09:20:00Z", "section_name": "U.S."}], "meta": {"hits": 5, "offset": 0, "time": 37}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}